Update - Notification of buy-back - VLS
other announcement
Latest articles and price-sensitive announcements with AI sentiment classification.
other announcement
How Did Vita Life Sciences (ASX:VLS) Lift Half-Year Profit by 14.9% and Declare a 5.0 Cent Dividend? Kalkine
other announcement
director_dealing announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
Vita Life Sciences Limited (ASX:VLS) reported a daily buy-back transaction involving the acquisition of 8,000 fully paid ordinary shares on 18 September 2026, increasing the total shares repurchased under its on-market buy-back scheme to 324,184 by the close of that day. Key Points On 18 September 2026, Vita Life Sciences bought back 8,000 fully paid ordinary VLS shares for AUD 22,220.00 in total consideration. The share price paid on that day was AUD 2.75 per share, consistent for both the h...
other announcement
other announcement
other announcement
ASX Watchlist September 2026: What Could Put Vita Life Sciences (ASX:VLS) on Investors’ Radar? Kalkine
Is It Smart To Buy Vita Life Sciences Limited (ASX:VLS) Before It Goes Ex-Dividend? simplywall.st
other announcement
other announcement
Vita Life Sciences (ASX:VLS): Consumer Health Exposure and Partly Franked Income in Focus Kalkine
other announcement
Have Vita Life Sciences Insiders Been Selling Stock? simplywall.st
director_dealing announcement
other announcement
other announcement
Highlights Vita Life Sciences continues its on-market share buy-back, keeping capital management in focus. Regular ASX disclosures provide transparency around the company's ongoing share repurchase activity. The healthcare business adds a capital-management angle to Australia's listed healthcare sector. Why Is Vita Life Sciences Back in Focus? Vita Life Sciences has drawn fresh attention after updating the ASX on its continuing on-market share buy-back programme. The Australian healthcare comp...
other announcement
other announcement
Vita Life Sciences (ASX:VLS) Interim Dividend — Can Healthcare Growth Keep Supporting This Small-Cap Income Story? Kalkine
Vita Life Sciences (ASX:VLS) Shares Reflect A Stronger Margin Story simplywall.st
How Vita Life Sciences (ASX:VLS) Balances Shareholder Returns with Healthcare Growth Kalkine
Kalkine ASX News: Vita Life Sciences (ASX:VLS) Advances as Investors Assess Earnings Guidance Kalkine